Insider Transactions in Q3 2024 at Longboard Pharmaceuticals, Inc. (LBPH)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 16
2024
|
Randall Kaye Executive Vice President & CMO |
SELL
Open market or private sale
|
Direct |
16,666
-14.76%
|
$533,312
$32.47 P/Share
|
|
Sep 16
2024
|
Randall Kaye Executive Vice President & CMO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,666
+32.52%
|
$66,664
$4.35 P/Share
|
|
Aug 12
2024
|
Randall Kaye Executive Vice President & CMO |
SELL
Open market or private sale
|
Direct |
16,667
-27.98%
|
$566,678
$34.79 P/Share
|
|
Aug 12
2024
|
Randall Kaye Executive Vice President & CMO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,667
+32.52%
|
$66,668
$4.35 P/Share
|
|
Aug 12
2024
|
Kevin Robert Lind President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
82,482
+8.14%
|
$247,446
$3.66 P/Share
|